Press release
Immunoglobulin Market Set to Surge to USD 24.9 Billion by 2032 at a 5.1% CAGR
๐๐ฅ๐จ๐๐๐ฅ ๐๐ฆ๐ฆ๐ฎ๐ง๐จ๐ ๐ฅ๐จ๐๐ฎ๐ฅ๐ข๐ง ๐๐ง๐๐ฎ๐ฌ๐ญ๐ซ๐ฒ: ๐๐๐ฒ ๐๐ญ๐๐ญ๐ข๐ฌ๐ญ๐ข๐๐ฌ ๐๐ง๐ ๐๐ง๐ฌ๐ข๐ ๐ก๐ญ๐ฌ ๐ข๐ง ๐๐๐๐-๐๐๐๐๐๐ฎ๐ฆ๐ฆ๐๐ซ๐ฒ:
โ The global immunoglobulin market size reached USD 15.7 Billion in 2023.
โ The market is expected to reach USD 24.9 Billion by 2032, exhibiting a growth rate (CAGR) of 5.1% during 2024-2032.
โ North America leads the market, accounting for the largest immunoglobulin market share.
โ IgG accounts for the majority of the market share in the product segment due to IgG's effectiveness and safety profile.
โ Immunodeficiency disease holds the largest share in the immunoglobulin industry.
โ Intravenous mode of delivery remains a dominant segment in the market owing to the established protocols and healthcare infrastructure for intravenous administration.
โ The rising prevalence of immunodeficiency diseases is a primary driver of the immunoglobulin market.
โ The increasing Awareness and diagnosis of immunodeficiency diseases is reshaping the immunoglobulin market.
๐๐๐ช๐ฎ๐๐ฌ๐ญ ๐๐จ๐ซ ๐ ๐ฌ๐๐ฆ๐ฉ๐ฅ๐ ๐๐จ๐ฉ๐ฒ ๐จ๐ ๐ญ๐ก๐ข๐ฌ ๐ซ๐๐ฉ๐จ๐ซ๐ญ:ย https://www.imarcgroup.com/immunoglobulin-market/requestsample
๐๐ฆ๐ฆ๐ฎ๐ง๐จ๐ ๐ฅ๐จ๐๐ฎ๐ฅ๐ข๐ง ๐๐ง๐๐ฎ๐ฌ๐ญ๐ซ๐ฒ ๐๐ซ๐๐ง๐๐ฌ ๐๐ง๐ ๐๐ซ๐ข๐ฏ๐๐ซ๐ฌ:
โ ๐๐ข๐ฌ๐ข๐ง๐ ๐ฉ๐ซ๐๐ฏ๐๐ฅ๐๐ง๐๐ ๐จ๐ ๐ข๐ฆ๐ฆ๐ฎ๐ง๐จ๐๐๐๐ข๐๐ข๐๐ง๐๐ฒ ๐๐ข๐ฌ๐๐๐ฌ๐๐ฌ:
As the number of individuals diagnosed with primary immunodeficiency diseases and secondary immunodeficiencies is growing, there is a higher demand for immunoglobulin therapies to manage and treat these conditions. Immunoglobulin therapies are critical for patients with immunodeficiencies, as they provide necessary antibodies to help the body fight infections. This creates a consistent demand for immunoglobulin products. Enhanced awareness and advancements in diagnostic techniques have led to earlier detection of immunodeficiency diseases. This results in timely treatment with immunoglobulin therapies, increasing overall market demand. Many patients with immunodeficiency require lifelong immunoglobulin therapy, leading to sustained usage and a stable market demand. This chronic treatment aspect fosters ongoing revenue for manufacturers.
โ ๐๐ ๐ข๐ง๐ ๐๐จ๐ฉ๐ฎ๐ฅ๐๐ญ๐ข๐จ๐ง:
Older adults often have weakened immune systems, making them more susceptible to infections and chronic diseases. This demographic requires more immunoglobulin therapies to help bolster their immune response. As people age, they are more likely to develop chronic conditions, such as diabetes, heart disease, and autoimmune disorders. Immunoglobulin therapies are increasingly used to manage complications associated with these conditions, leading to greater demand. Diseases that commonly affect older populations, like Alzheimer's disease, Parkinson's disease, and various forms of cancer, can benefit from immunoglobulin treatment, creating a need for these therapies. The elderly often require long-term care and management of multiple health issues, leading to a consistent need for immunoglobulin therapies. This ongoing treatment need fosters a stable market for immunoglobulin products.
โ ๐๐ง๐๐ซ๐๐๐ฌ๐ข๐ง๐ ๐๐ฐ๐๐ซ๐๐ง๐๐ฌ๐ฌ ๐๐ง๐ ๐๐ข๐๐ ๐ง๐จ๐ฌ๐ข๐ฌ:
Improved awareness among healthcare providers and the public about immunodeficiency diseases has led to earlier diagnosis. Early intervention with immunoglobulin therapies is crucial for effective management, resulting in higher demand. As patients become more informed about their health conditions, they are more likely to seek medical attention. This proactive approach leads to more diagnoses of immunodeficiency disorders, increasing the patient population in need of immunoglobulin treatment. Ongoing education and training programs for healthcare professionals about immunodeficiency diseases and their treatment options have improved diagnostic rates and treatment outcomes. This professional awareness promotes the prescription of immunoglobulin therapies. The development of advanced diagnostic technologies has facilitated the accurate identification of immunodeficiencies. Improved testing methods increase the likelihood of diagnosis, leading to more patients receiving necessary immunoglobulin treatments.
๐๐ฎ๐ฒ ๐ ๐ฎ๐ฅ๐ฅ ๐๐๐ฉ๐จ๐ซ๐ญ:ย https://www.imarcgroup.com/checkout?id=4505&method=502
๐๐ฆ๐ฆ๐ฎ๐ง๐จ๐ ๐ฅ๐จ๐๐ฎ๐ฅ๐ข๐ง ๐๐๐ซ๐ค๐๐ญ ๐๐๐ฉ๐จ๐ซ๐ญ ๐๐๐ ๐ฆ๐๐ง๐ญ๐๐ญ๐ข๐จ๐ง:
๐๐ซ๐๐๐ค๐ฎ๐ฉ ๐๐ฒ ๐๐ซ๐จ๐๐ฎ๐๐ญ:
โ IgG
โ IgA
โ IgM
โ IgE
โ IgD
IgG represents the largest segment as IgG is the most abundant immunoglobulin in human serum and is widely used for various therapeutic applications.
๐๐ซ๐๐๐ค๐ฎ๐ฉ ๐๐ฒ ๐๐ฉ๐ฉ๐ฅ๐ข๐๐๐ญ๐ข๐จ๐ง:
โ Hypogammaglobulinemia
โ Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
โ Immunodeficiency Disease
โ Myasthenia Gravis
โ Others
Immunodeficiency disease accounts for the majority of the market share. Immunodeficiency diseases require ongoing treatment with immunoglobulin therapies, resulting in a substantial demand that accounts for a significant portion of market share.
๐๐ซ๐๐๐ค๐ฎ๐ฉ ๐๐ฒ ๐๐จ๐๐ ๐จ๐ ๐๐๐ฅ๐ข๐ฏ๐๐ซ๐ฒ:
โ Intravenous Mode of Delivery
โ Subcutaneous Mode of Delivery
Intravenous mode of delivery exhibits a clear dominance in the market due to its rapid administration and higher plasma levels of immunoglobulin, making it the preferred method for many clinicians and patients.
๐๐ซ๐๐๐ค๐ฎ๐ฉ ๐๐ฒ ๐๐๐ ๐ข๐จ๐ง:
โ North America (United States, Canada)
โ Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
โ Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
โ Latin America (Brazil, Mexico, Others)
โ Middle East and Africa
North America enjoys the leading position in the immunoglobulin market on account of its well-established healthcare infrastructure, higher prevalence of immunodeficiency diseases, and greater access to advanced treatment options.
๐๐จ๐ฉ ๐๐ฆ๐ฆ๐ฎ๐ง๐จ๐ ๐ฅ๐จ๐๐ฎ๐ฅ๐ข๐ง ๐๐๐ซ๐ค๐๐ญ ๐๐๐๐๐๐ซ๐ฌ:
The immunoglobulin market research report outlines a detailed analysis of the competitive landscape, offering in-depth profiles of major companies. Some of the key players in the market are:
โ ADMA Biologics Inc.
โ Baxter international Inc.
โ Biotest AG
โ CSL Limited
โ Grifols S.A
โ Kedrion S.p.A
โ LFB SA
โ Octapharma AG
โ Sanquin Plasma Products B.V.
โ Takeda Pharmaceutical Company Limited
๐๐ญ๐ก๐๐ซ ๐๐๐ฅ๐๐ญ๐๐ ๐๐๐ฉ๐จ๐ซ๐ญ๐ฌ ๐๐ฒ ๐๐๐๐๐ ๐๐ซ๐จ๐ฎ๐ฉ
๐๐ข๐ซ ๐๐๐๐๐ง๐ฌ๐ ๐๐ฒ๐ฌ๐ญ๐๐ฆ๐ฌ ๐๐๐ซ๐ค๐๐ญ:ย https://www.imarcgroup.com/air-defense-systems-market
๐๐จ๐ฆ๐๐ข๐ง๐ ๐๐๐ซ๐ฏ๐๐ฌ๐ญ๐๐ซ๐ฌ ๐๐๐ซ๐ค๐๐ญ:ย https://www.imarcgroup.com/combine-harvesters-market
๐๐จ๐ฆ๐ฆ๐๐ซ๐๐ข๐๐ฅ ๐๐๐๐ซ๐ข๐ ๐๐ซ๐๐ญ๐ข๐จ๐ง ๐๐๐ซ๐ค๐๐ญ:ย https://www.imarcgroup.com/commercial-refrigeration-market
๐๐จ๐จ๐ ๐๐ฎ๐ฅ๐ฉ ๐๐๐ซ๐ค๐๐ญ:ย https://www.imarcgroup.com/wood-pulp-market
๐๐๐ญ๐๐ข๐ฅ ๐๐๐๐๐ฒ ๐๐๐๐ค๐๐ ๐ข๐ง๐ ๐๐๐ซ๐ค๐๐ญ:ย https://www.imarcgroup.com/retail-ready-packaging-market
๐๐จ๐ญ๐: ๐๐ ๐ฒ๐จ๐ฎ ๐ซ๐๐ช๐ฎ๐ข๐ซ๐ ๐๐ง๐ฒ ๐ฌ๐ฉ๐๐๐ข๐๐ข๐ ๐ข๐ง๐๐จ๐ซ๐ฆ๐๐ญ๐ข๐จ๐ง ๐ญ๐ก๐๐ญ ๐ข๐ฌ ๐ง๐จ๐ญ ๐๐จ๐ฏ๐๐ซ๐๐ ๐๐ฎ๐ซ๐ซ๐๐ง๐ญ๐ฅ๐ฒ ๐ฐ๐ข๐ญ๐ก๐ข๐ง ๐ญ๐ก๐ ๐ฌ๐๐จ๐ฉ๐ ๐จ๐ ๐ญ๐ก๐ ๐ซ๐๐ฉ๐จ๐ซ๐ญ, ๐ฐ๐ ๐ฐ๐ข๐ฅ๐ฅ ๐ฉ๐ซ๐จ๐ฏ๐ข๐๐ ๐ญ๐ก๐ ๐ฌ๐๐ฆ๐ ๐๐ฌ ๐ ๐ฉ๐๐ซ๐ญ ๐จ๐ ๐ญ๐ก๐ ๐๐ฎ๐ฌ๐ญ๐จ๐ฆ๐ข๐ณ๐๐ญ๐ข๐จ๐ง.
๐๐จ๐ง๐ญ๐๐๐ญ ๐๐ฌ:
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
Email: sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
United States: +1-631-791-1145
๐๐๐จ๐ฎ๐ญ ๐๐ฌ:
IMARC Group is a global management consulting firm that helps the world's most ambitious changemakers to create a lasting impact. The company provide a comprehensive suite of market entry and expansion services. IMARC offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Immunoglobulin Market Set to Surge to USD 24.9 Billion by 2032 at a 5.1% CAGR here
News-ID: 3692639 • Views: โฆ
More Releases from IMARC Group
Polyvinyl Chloride Market Forecast 2025-2033 Supported by Construction Demand an โฆ
Market Overview
The global polyvinyl chloride market was valued at USD 47.0 Billion in 2024 and is expected to reach USD 65.7 Billion by 2033, growing at a CAGR of 3.6% during 2025-2033. The market growth is driven by the increasing use of durable and flexible materials in consumer products, rising personal car ownership, and enhanced wire insulation in electronic devices.
Study Assumption Years
โข Base Year: 2024
โข Historical Year/Period: 2019-2024
โข Forecast Year/Period: 2025-2033
Polyvinyl Chlorideโฆ
Vietnam IoT Market to Hit USD 14.6 Million by 2034 with a Robust CAGR of 13.52%
The Vietnam IoT market size reached USD 4.7 Million in 2025. It is projected to grow to USD 14.6 Million by 2034, exhibiting a CAGR of 13.52% during the forecast period 2026-2034. This growth is driven by expansions in manufacturing, industrial sectors, population increase, and the expansion of 5G networks. The IoT ecosystem is transforming sectors like agriculture, transportation, and healthcare with smart city initiatives improving infrastructure and public services.โฆ
Vietnam Ceramic Tiles Market Size, Share, Growth, Demand And Report 2026-2034
The Vietnam ceramic tiles market size was valued at USD 399.6 Million in 2025. It is expected to grow at a CAGR of 11.40% during the forecast period 2026-2034, reaching USD 1,056.2 Million by 2034. Key market drivers include increasing infrastructural development, rising consumer disposable income, urbanization, technological innovations, and supportive government policies. These factors are fueling demand across residential and commercial construction sectors.
Sample Request Link: https://www.imarcgroup.com/vietnam-ceramic-tiles-market/requestsample
Study Assumption Years
Base Year:โฆ
Vietnam Jewellery Market to Hit USD 2.90 Billion by 2033 with a Robust CAGR of 4 โฆ
The Vietnam jewellery market size reached USD 1.83 Billion in 2024 and is projected to grow to USD 2.90 Billion by 2033, representing a CAGR of 4.60% during the forecast period from 2025 to 2033. Growth is driven by rising disposable incomes, cultural traditions, urbanization, and expanding retail and e-commerce channels, with gold's appeal as a safe-haven asset amid economic fluctuations.
Sample Request Link: https://www.imarcgroup.com/vietnam-jewellery-market/requestsample
Study Assumption Years
Base Year: 2024
Historical Years: 2019-2024
Forecastโฆ
More Releases for Immunoglobulin
Immunoglobulin Market Forecast 2035 | Advancing Therapeutic Outcomes: Growth of โฆ
An extensive study of propelling opportunities in, "Immunoglobulin Market Size, Share & Trends Analysis Report by Product Type (IgG, IgA, IgM, IgE, IgD), Form, Route of Administration, Application, Source, Technology, Therapy Type, Patient Demographics, End-user / Distribution Channel and Geography (North America, Europe, Asia Pacific, Middle East, Africa, and South America) - Global Industry Data, Trends, and Forecasts, 2025-2035" A comprehensive report of growing market landscapes in the immunoglobulin sectorโฆ
Rabies Immunoglobulin Market - Dynamics and Growth Pattern
The "Rabies Immunoglobulin Market" forecast 2031 report analyses the present and future competitive scenario of the analytics industry. Rabies Immunoglobulin Market report offers an in-depth analysis on segments including top companies, products, applications, revenue and regions. a number of topics including likewise market share, drivers, trends and methods. This report additionally offers insights into the latest growth and trends. It encapsulates key aspects of the market, with focus on leadingโฆ
Key Subcutaneous Immunoglobulin (SCIG) Market Trend for 2025-2034: Advancements โฆ
What Is the Future Outlook for the Subcutaneous Immunoglobulin (SCIG) Market's Size and Growth Rate?
There has been a rapid expansion in the subcutaneous immunoglobulin (SCIG) market size in the previous years. It's projected to swell from $12.72 billion in 2024 to $14.52 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 14.1%. The upsurge in the past era is credited to the heightened occurrence of immunodeficiency disorders,โฆ
Intravenous Immunoglobulin Market CAGR of intravenous immunoglobulin market is t โฆ
The report is designed to provide a holistic view of the Intravenous Immunoglobulin Market .It provides the industry overview with market growth analysis with a historical & futuristic perspective for the following parameters; revenue, demands, and supply data (as applicable). Regional estimates and forecasts & trend analysis for eac country (U.S., Canada, Mexico, Germany, France, U.K., Italy, Spain, Russia, Turkey, Belgium, Netherlands, Switzerland, Luxemburg, Rest of Europe, Japan, China, Southโฆ
Intravenous Immunoglobulin Market CAGR of intravenous immunoglobulin market is t โฆ
The report is designed to provide a holistic view of the Intravenous Immunoglobulin Market . It provides the industry overview with market growth analysis with a historical & futuristic perspective for the following parameters; revenue, demands, and supply data (as applicable). Regional estimates and forecasts & trend analysis for eac country (U.S., Canada, Mexico, Germany, France, U.K., Italy, Spain, Russia, Turkey, Belgium, Netherlands, Switzerland, Luxemburg, Rest of Europe, Japan, China,โฆ
Immunoglobulin Market 2021 | Detailed Report
Global Immunoglobulin Market 2021-2027, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market. An exclusive data offered in this report is collected by research and industry experts team.
Get Free Sample PDF (including full TOC, Tables and Figures) ofโฆ
